Amir Beker focuses on digital health technologies, data-science-based biomedical solutions, and medical devices. He is the founder of BSP Biological Signal Processing, a digital health company in the field of non-invasive cardiology, which he led to an IPO on the Tel Aviv Stock Exchange, serving as CEO and chairman of the company. Amir is a co-founder and partner in HealthTech companies including Identifai Genetics, a digital bioinformatics company developing novel noninvasive prenatal screening solutions, and Accyourate, a European medical device corporate offering innovative wearable monitoring devices. Amir gained executive experience as a managing partner in Pamot VC, an early-stage VC fund, where he also served as acting CEO in portfolio companies. Amir holds a PhD in physics from Tel Aviv University, he is a graduate of “Talpiot” program of the Israel Defense Forces and held an R&D officer post in the Israeli Air Force